Dubai to Host Dubai Woodshow’s 21st Edition, from April 14th to 16th, 2025
16.9.2024 08:30:00 CEST | Business Wire | Press release
Dubai is gearing up to host the 21st edition of Dubai Woodshow, the premier international trade fair focusing on the wood, furniture, and woodworking machinery industries in the MENA region (Middle East and North Africa), gathering more than 600 exhibitors from +50 countries around the world.
Scheduled from April 14 to 16 at the Dubai World Trade Centre, the prestigious event will bring together industry professionals, manufacturers, suppliers and wood machinery and tools specialists, to showcase the latest products, services and technologies in the industry. It will also provide an exciting platform to display a wide variety of wood and woodworking machinery and tools, attracting international investors and businessmen to the region, which contributes to driving economic diversification and industrial advancement.
Dubai WoodShow offers exhibitors the opportunity to connect with their existing customers and discuss prospects and possible synergies to expand their business, while identifying potential customers from new markets, promoting their brands, exchanging views, experiences and knowledge and communicating with interested government entities. Those who are interested in the show can register online by visiting https://www.woodshowglobal.com/dubai.
The exhibition attracts more than 15,000 visitors from over 130 countries annually, making it the premier destination for wood exporters and key players in the sector from around the globe, and a platform for hundreds of exhibitors to gather under one roof and meet with local and international building materials suppliers, distributors & dealers, furniture & machinery manufacturers, architects, interior designers, contractors and developers.
The Dubai Woodshow offers a variety of events, most notably the conference, which includes seminars and keynote speeches with experts, senior government officials and industry specialists, to exchange views, experiences, and knowledge on the latest developments and trends in local, regional and global markets.
The event will also facilitate communication and bilateral meetings between investors and participating entities, to discuss opportunities and potential partnership deals. It also allows exhibitors to showcase their products to an international audience. Innovation Awards will be also presented to innovators from the wood and woodworking machinery industry.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as accommodation only and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20240915176252/en/
Contacts
Shereen al Musalami
Shereen al Musalami
shereen.almusallami@strategic.ae
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom